Laboratory X LT - Company finances
|
EUR
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 33,314 | 119,292 | 211,544 | 207,136 | 273,641 |
| Profit before tax | - | - | - | - | - |
| Net profit | -2,906 | 24,711 | 62,905 | 52,287 | -14,418 |
| Equity | -406 | 24,305 | 87,209 | 139,496 | 125,078 |
| Liabilities | 3,903 | 5,490 | 4,017 | 2,446 | 27 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 |
| Current assets | 3,497 | 29,795 | 91,226 | 141,942 | 125,105 |
| Total assets | 3,497 | 29,795 | 91,226 | 141,942 | 125,105 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 1,526 | 4,408 | 3,085 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | +258.1% | +77.3% | -2.1% | +32.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -83.1% | 82.9% | 69.0% | 36.8% | -11.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 101.7% | 72.1% | 37.5% | -11.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -8.7% | 20.7% | 29.7% | 25.2% | -5.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.2 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 33,314 | 119,292 | 211,544 | 207,136 | 273,641 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Laboratory X LT - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-13 | 183.93 |
| 2026-08-19 | 2026-08-19 | 183.93 |
| 2022-11-21 | 2022-12-06 | 0.09 |
| 2022-11-17 | 2022-11-18 | 0.09 |
| 2022-10-18 | 2022-11-09 | 0.09 |
| 2022-09-16 | 2022-10-05 | 0.09 |
| 2022-08-23 | 2022-09-12 | 0.09 |
| 2022-07-18 | 2022-08-08 | 0.09 |
| 2022-06-16 | 2022-07-10 | 0.09 |
| 2022-05-17 | 2022-06-07 | 0.09 |
| 2022-04-28 | 2022-05-08 | 0.09 |
Laboratory X LT - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Laboratory X LT, UAB (code 305651217) is a Private Limited Liability Company engaged in business and other management consultancy activities. In 2025, the company generated revenue of €273.6K, up 32.1% year on year and 29.4% over two years. Despite this stronger top-line performance, it posted a net loss of €14.4K after net profits of €52.3K in 2024 and €62.9K in 2023. The 2025 profit margin therefore turned negative at -5.3%, compared with 25.2% in 2024 and 29.7% in 2023. Balance sheet size remained modest, with total assets of €125.1K and equity of €125.1K at year-end 2025, while liabilities were only €27. Asset turnover was 2.19x, indicating relatively efficient use of assets to generate revenue. Return on equity and return on assets were both -11.5% in 2025, reflecting the loss recorded for the year. Revenue per employee was €273.6K, matching the latest revenue figure, and profit per employee was -€14.4K.